ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Bbva Intl 14

Bbva Intl 14 (60FZ)

0.00
0.00
( 0.00% )

Empower your portfolio: Real-time discussions and actionable trading ideas.

60FZ News

Official News Only
0 articles were found

Discussion

View Full Feed
Wayne R Wayne R 50 seconds ago
Eggs are not sold refrigerated here, in fact the top chefs say NEVER refrigerate eggs.

Having said that, my wife always puts them in the fridge.

I just don't care enough about eggs to get into a discussion about it. 😉
mikepgator mikepgator 55 seconds ago
Dude they are literally replying to an Isopet post.
RDGL
Monksdream Monksdream 1 minute ago
Top 15 at 8:30
https://ih.advfn.com/markets/nasdaq/premarket
BullNBear52 BullNBear52 2 minutes ago
~~COMPX 3/7/2025~~~~~~~

Previous Close

18069.26 -483.48

18199 BullNBear52
18285 SSKILLZ1
COMP
Trooperstocks Trooperstocks 2 minutes ago
$COEP Coeptis Therapeutics "We're thrilled to announce the successful closure of our second Series A Preferred financing," said Brian Cogley, CFO of COEPTIS. "This funding is pivotal as we expand our operational capabilities and enhance shareholder value through our new Technology Division. #COEPTIS
COEP
Trooperstocks Trooperstocks 2 minutes ago
$COEP Coeptis Therapeutics "We're thrilled to announce the successful closure of our second Series A Preferred financing," said Brian Cogley, CFO of COEPTIS. "This funding is pivotal as we expand our operational capabilities and enhance shareholder value through our new Technology Division. #COEPTIS
COEP
TucsonPhil TucsonPhil 2 minutes ago
A local should go jiggle the locked door and give us some pictures.
KGKG
uranium-pinto-beans uranium-pinto-beans 3 minutes ago
CGON
CG Oncology assumed with an Overweight at Morgan Stanley
Morgan Stanley assumed coverage of CG Oncology with an Overweight rating and $55 price target. Morgan Stanley sees a competitive profile for cretostimogene in bladder cancer, with indication expansion potential beyond hig
BCG
Budots Budots 3 minutes ago
Nasdaq: $CYCU, a trusted leader in IT cybersecurity solutions and AI, announced a nationwide expansion of its strategic partnership with CentralSquare Technologies, LLC to deliver its IT services across the country. https://finance.yahoo.com/news/cycurion-nasdaq-cycu-partners-centralsquare-134500799
CYCU
iateclube iateclube 3 minutes ago
Maybe a dead rabbit? Would be nice if Eutectix could step in a s the domestic manufacturer.
LQMT
Budots Budots 3 minutes ago
Nasdaq: $CYCU, a trusted leader in IT cybersecurity solutions and AI, announced a nationwide expansion of its strategic partnership with CentralSquare Technologies, LLC to deliver its IT services across the country. https://finance.yahoo.com/news/cycurion-nasdaq-cycu-partners-centralsquare-134500799
CYCU
uranium-pinto-beans uranium-pinto-beans 3 minutes ago
CGON
CG Oncology assumed with an Overweight at Morgan Stanley
Morgan Stanley assumed coverage of CG Oncology with an Overweight rating and $55 price target. Morgan Stanley sees a competitive profile for cretostimogene in bladder cancer, with indication expansion potential beyond hig
BCG
getmoreshares getmoreshares 4 minutes ago
nvni- .2465
Trooperstocks Trooperstocks 4 minutes ago
$BURU -HUMBL, Inc. Announces $2 Million Share Exchange Agreement and Strategic Partnership With NUBURU, Inc. to Accelerate Growth and Shareholder Value
https://finance.yahoo.com/news/humbl-inc-announces-2-million-230000447.html
BURU
Trooperstocks Trooperstocks 4 minutes ago
$BURU -HUMBL, Inc. Announces $2 Million Share Exchange Agreement and Strategic Partnership With NUBURU, Inc. to Accelerate Growth and Shareholder Value
https://finance.yahoo.com/news/humbl-inc-announces-2-million-230000447.html
BURU
TucsonPhil TucsonPhil 4 minutes ago
Nvidia's dropping of this stock has killed its momentum. Wouldn't be surprised by silent buying, at lower prices, followed up by new endorsements. Dirty pool, but somehow these tactics are not illegal, or if they are, SEC doesn't pursue charges.
SOUN
MasterBlastr MasterBlastr 4 minutes ago
Continues to crater. Hard.
gp22 gp22 4 minutes ago
In more $ESLA @ $1.10s: Was a $12 SPAC deal....Given $16 one year target last week by highly regarded bio/pharma ETF...Hit $1.80s last week and backed off..$ESLA a repeat of Immuno $IOVA & $SMMT monster moves
Link: 9/29/24
https://finance.yahoo.com/news/estrella-immunopharma-achieves-c
ESLA IOVA SMMT
gp22 gp22 4 minutes ago
In more $ESLA @ $1.10s: Was a $12 SPAC deal....Given $16 one year target last week by highly regarded bio/pharma ETF...Hit $1.80s last week and backed off..$ESLA a repeat of Immuno $IOVA & $SMMT monster moves
Link: 9/29/24
https://finance.yahoo.com/news/estrella-immunopharma-achieves-c
ESLA IOVA SMMT
justkate justkate 5 minutes ago
I SEE YOU ARE STILL POSITIONING FOR MAIN BEAR STATUS.....GITS BETTER THAN YOU!!! JUST MARCHING ON!! GLTA!!
GITS
glenn1919 glenn1919 6 minutes ago
icon.....btog......uoka......muln..............................................................................................P/M
fredscott36 fredscott36 6 minutes ago
........LIBOR is 100% OVER - - - or at least the cases that impact the UWBI sewage dept.......NAOMI will CLICK CLICK when she gets a green light from the huddled legal beagles......????.......UBS, BAC and whichever other banks gotta make sure there are not any loose ends, moving forward.........
UBS
Anticipating Anticipating 7 minutes ago
Nice! SAPX 🎸
SAPX
Wayne R Wayne R 7 minutes ago
There ya go, you can be liaison for offshore operations.
MULN
juicyjuice10002 juicyjuice10002 7 minutes ago
There may have been arguments about not to rush into release but there were no objections about uplisting the twins. First move therefore will be uplisting to determine the potential market value.
FNMA

Your Recent History

Delayed Upgrade Clock